Brainsway (BWAY) CMO reports shares, RSUs and option grants

Rhea-AI Filing Summary

Brainsway Ltd. Chief Marketing Officer Naomi Rozenfeld filed an initial ownership report showing equity exposure through shares, RSUs and options. She holds 25,000 Ordinary Shares, including 25,000 unvested RSUs that begin vesting on March 10, 2027 and continue quarterly until March 10, 2030. She also holds stock options over 75,000 Ordinary Shares, granted on December 22, 2025, with 18,750 options vesting on December 22, 2026 and the rest vesting quarterly until December 22, 2029, at an exercise price of NIS 30.74 per share and expiring on December 22, 2035. The Ordinary Shares may also be represented by American Depositary Shares, each currently equal to one Ordinary Share.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rozenfeld Naomi

(Last) (First) (Middle)

16 HARTUM STREET, RAD TOWER, 14TH FLOOR

HAR HAHOTZVIM

(Street)

JERUSALEM 9777516

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Brainsway Ltd. [ BWAY ]

3a. Foreign Trading Symbol
[BWAY]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)(2)	25,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	(3)	12/22/2035	Ordinary Shares(1)	75,000	(4)	D

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. This figure includes 25,000 unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, with 6,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.

3. Stock options were granted on December 22, 2025, with options to purchase 18,750 ordinary shares vesting on December 22, 2026 and the remaining options vesting in equal quarterly installments until December 22, 2029.

4. The exercise price is NIS 30.74 per share.

	/s/ Naomi Rozenfeld	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

Who is the insider reporting ownership in Brainsway (BWAY)?

The filing shows Naomi Rozenfeld, Chief Marketing Officer of Brainsway Ltd., reporting her initial equity holdings. She is listed as an officer, not a director or 10% owner, and the report details her shares, RSUs, and stock options.

How many Brainsway (BWAY) Ordinary Shares does Naomi Rozenfeld hold?

Naomi Rozenfeld reports holdings of 25,000 Ordinary Shares. This figure includes 25,000 unvested RSUs, each convertible into one Ordinary Share upon vesting, giving her a structured path to future share ownership as vesting milestones are met.

What RSU vesting schedule is disclosed for Brainsway (BWAY) CMO Naomi Rozenfeld?

Rozenfeld has 25,000 unvested RSUs, each tied to one Ordinary Share. 6,250 RSUs vest on March 10, 2027, with the remaining RSUs vesting in equal quarterly installments until March 10, 2030, creating a multi-year alignment with company performance.

What stock options does Naomi Rozenfeld hold in Brainsway (BWAY)?

She holds stock options over 75,000 Ordinary Shares, granted on December 22, 2025. Options on 18,750 shares vest on December 22, 2026, with the rest vesting quarterly until December 22, 2029, and expiring on December 22, 2035.

What is the exercise price of Brainsway (BWAY) stock options held by Naomi Rozenfeld?

The disclosed stock options carry an exercise price of NIS 30.74 per share. This means Rozenfeld can purchase Ordinary Shares at that fixed price once her options vest and before they expire on December 22, 2035, subject to applicable plan terms.

How are Brainsway (BWAY) Ordinary Shares related to its American Depositary Shares?

The filing notes that Brainsway’s Ordinary Shares may be represented by American Depositary Shares (ADSs). Each ADS currently represents one Ordinary Share, providing an equivalent economic interest whether held as Ordinary Shares or ADSs.